Results 91 to 100 of about 61,121 (211)

A rare case of an unexpected trigger of paroxysmal atrial fibrillation in the right atrial appendage diverticulum

open access: yesBMC Cardiovascular Disorders
Introduction We described a rare case of an adolescent girl with paroxysmal atrial fibrillation originating from the right atrial appendage diverticulum and successfully converted to sinus rhythm after surgical intervention.
Li Cheng   +4 more
doaj   +1 more source

Atrial fibrosis in atrial fibrillation: Mechanisms, mapping techniques and clinical applications

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Summary of key aspects of atrial fibrosis in atrial fibrillation, highlighting atrial fibrosis as a hallmark of atrial fibrillation (AF). (1) Different types of fibrosis (blue), illustrating reparative and reactive fibrosis; (2) fibrosis detection techniques (green), illustrating late gadolinium enhancement cardiac magnetic ...
Caterina Vidal Horrach   +8 more
wiley   +1 more source

Deciphering pro‐arrhythmogenic mechanisms of EPAC in human atrial cardiomyocytes

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend This study aimed to investigate the effect of exchange proteins directly activated by cAMP (EPAC) on the regulation of human atrial cardiomyocyte electrophysiology and their potential involvement in the onset of atrial fibrillation (AF).
Arthur Boileve   +11 more
wiley   +1 more source

Small‐conductance Ca2⁺‐activated K⁺ channels in cardiac excitation–contraction coupling: Bridging mitochondria, sarcolemma and antiarrhythmic therapy

open access: yesThe Journal of Physiology, EarlyView.
Abstract figure legend Mitochondrial SK channel enhancement reduces cardiac arrhythmia trigger. Spontaneous sarcoplasmic reticulum (SR) Ca2+ release via hyperactive RyR2s underlies an increased arrhythmia trigger, promoting early and delayed afterdepolarizations during stress. Hyperactive RyR2s causes rise in cytosolic [Ca2+] during diastole. Clearance
Dmitry Terentyev   +7 more
wiley   +1 more source

Predictors and Outcomes of 30‐Day Readmissions Following Electrical Cardioversion for Atrial Fibrillation: Insights From the Nationwide Readmissions Database

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
Among 134 114 atrial fibrillation hospitalizations treated with electrical cardioversion in the 2016–2017 NRD, 9.9% resulted in 30‐day readmission. Readmission was associated with higher mortality, longer stay and greater costs. Predictors included cardiometabolic comorbidities, female sex, lower income, Medicare/Medicaid insurance, nonhome discharge ...
Adeena Jamil   +12 more
wiley   +1 more source

Documented Obstructive Sleep Apnea, Cardiometabolic Phenotype, and Rhythm‐Related Outcomes After Atrial Fibrillation Ablation: An Observational Cohort Study

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
Documented OSAS identified a higher‐risk cardiometabolic phenotype in patients undergoing AF ablation, including greater obesity, hypertension, diabetes, persistent AF, and adverse lipid markers. However, it did not independently predict post‐ablation rhythm‐related outcomes in either the registry cohort or the actively followed cohort.
Yazan Mohsen   +9 more
wiley   +1 more source

Radiation dose optimization in coronary CT angiography clinical application of absolute phase gating in patients with atrial fibrillation

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 7, July 2026.
Abstract Background Atrial fibrillation (AF) poses significant challenges for coronary CT angiography (CCTA) due to R‐R interval variability, often necessitating high radiation dose protocols. Absolute phase gating, which uses fixed millisecond delays rather than percentage‐based cardiac cycle timing, may optimize image quality while reducing radiation
Yuyang Li
wiley   +1 more source

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience

open access: yesAmerican Journal of Hematology, Volume 101, Issue 7, Page 1597-1604, July 2026.
ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo   +38 more
wiley   +1 more source

A Nomogram utilizing ECG P-wave parameters to predict recurrence risk following catheter ablation in paroxysmal atrial fibrillation

open access: yesJournal of Cardiothoracic Surgery
Highlights Abnormal changes in P-wave parameters indicative of atrial electrical remodeling often manifest earlier than changes in other indicators reflecting atrial structural remodeling in paroxysmal atrial fibrillation. Preoperative absolute values of
Li-juan Yu   +4 more
doaj   +1 more source

Ethanol Infusion Into the Vein of Marshall for Atrial Fibrillation: Clinical Efficacy and Technical Limitations

open access: yesClinical Cardiology, Volume 49, Issue 7, July 2026.
Evaluating EIVOM in atrial fibrillation: Clinical efficacy, mechanistic insights, and technical considerations. Abbreviations: AF, atrial fibrillation; AT, atrial tachycardia; CS, coronary sinus; EIVOM, ethanol infusion into the vein of Marshall; LAA, left atrial appendage; LIPV, left inferior pulmonary vein; MA, mitral annulus; MI, mitral isthmus; RF,
Xuepeng Zheng   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy